S. Joannes Paulus, II, International District of Healthcare to open at SmartCity Malta
A new private hospital, S. John Paul II, will be setting-up operations in SmartCity Malta.
The medical centre of excellence, which will be equipped with the latest technology, will mainly operate in the field of orthopaedics, with surgical and outpatient activity, and will only perform scheduled operations, including osteology surgical procedures and neurosurgery. This new foreign direct investment was conceived by an international management team of experienced managers and professionals in the healthcare field, medical opinion leaders and surgeons who benefit from a wealth of knowledge and experience in the health sector. Other specific activities will include day surgery in the urology, ophthalmology, angiology, maxillofacial surgery and dental implantology fields. While S. John Paul II Hospital will give great attention to the quality of medical performances, it will constantly also keep abreast of innovation and feasibility.
This was announced by Francesco Rosi, company director during the signing ceremony held at Smart City Malta in the presence of the Prime Minister of Malta, Joseph Muscat, the Minister for Energy and Health, Konrad Mizzi, Parlimentary Secretary for Health, Christopher Fearne and Anthony Tabone, Chief Executive Officer of SmartCity Malta.
Speaking about the project, Dr Rosi explained: “The basis of this project aims to create a medical centre of excellence in the centre of the Mediterranean, which may eventually be replicated elsewhere. Malta was thus chosen for this venture which will focus specifically on the care, and physical and psychological well-being of patients.”
“We chose to operate from SmartCity Malta, the knowledge-based business township, for a variety of reasons, including the project’s world-class intelligent infrastructure designed for assured business continuity, the thoughtful environment it offers and its responsive support system. Another contributing factor is SmartCity Malta’s objective to create a network of opportunities that is already home to knowledge-based companies aiming to serve the EU and North African markets. Additionally, the surrounding landscape of SmartCity Malta provides the ideal place for respite where one can feel at ease and take in the breathtaking vistas of the lagoon and the sea,” he added.
The hospital will consist of 23,500 square meters, with an underlying parking for 500 cars and will directly employ circa 500 people, including doctors, nurses, physiotherapists and administrative and other related staff. Whilst providing opportunities to Maltese professionals, S. John Paul II Hospital will also target international professionals in the healthcare industry.
S. John Paul II Hospital does not aim to create a traditional hospital with more specialized branches, but rather a 200 bed facility with a prevailing speciality: that of always keeping the patient at the centre of all endeavours, taking charge of all problems, especially psychological difficulties, and the retrieval of well-being and lost mobility through the latest innovative techniques and technologies.
Key elements of the Project:
The structure is substantially a mono-specialistic one, mainly operating in the field of orthopaedics and neurology, carrying out a number of highly critical surgical interventions. It will also constitute an important platform for applied research and the possibility of developing new techniques in micro-invasive surgery, followed by forefront rehabilitation. These new techniques reduce the actual operating time, post-operative hospital stays within the hospital, and positively impact the cost.
The centre will pay great attention to diagnostic imaging technology, hi-tech organisation systems of the operating theatres and outpatient services. In light of this, the facility is currently developing a partnership with a forefront multinational company, which would result in Malta becoming a reference area in science and technology in the healthcare field, and thus, continuing to attract medical tourism.
The strategic alliance with Johnson & Johnson Medical, is an innovative element, which goes beyond the simple supplier relationship of health centres. It is a strategic partnership that puts together the research and technology of the largest medical group of companies worldwide with the clinical activity of the medical centre, thereby aiming to achieve a number of specialised services necessary for the development of research. It is a partnership that would then go on to develop training and applied research, which is essential for excellence in a hospital environment.
Education and Research will be strengthened in the clinical aspect, through the creation of a cadaver lab, an important aspect in teaching and research (also as e-learning), supporting the development of surgical techniques in all activities undertaken in the health facility. The facility will be equipped with training rooms utilizing the latest technologies for shooting in high definition and the transmission of images recorded in the operating room during surgical activities.
The health facility will be built on an area of over 16,000 square metres of land of which 8,000 square metres will be allocated for a sports medicine centre. A programme is being developed with the IOC (International Olympic Committee) and the FMSI (Italian National Federation of Sports Medicine). It is the company’s goal to achieve specific high level programmes in sports medicine, and hence attract athletes from various sports disciplines.
“The Mediterranean Institute for Personalised Medicine” is one of the largest applied research projects, which the company intends to launch. The Company, together with the Italian Society of Personalized Medicine, will launch a cutting-edge technology platform, which allows to draw a molecular map of a patient, serving as a guide to the choice of preventive and therapeutic customised strategies.
The methodology characterises in detail the molecular and metabolic footprint, with medical decisions, practices, and products being tailored to the individual patient. In this model, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Such data is key to counter the ineffectiveness and toxicity of therapies.
The approach is of considerable importance to improve the quality of life of the patient, who has the possibility to avoid, or at least delay the development of diseases, as well as to optimise the medical therapies for pathologies in place. Personalised Medicine also represents an innovative strategy for the proper management of health resources, reducing the social and economic impact of the disease. Given the socio-economic benefits of "Personalised Medicine", the health facility will invest in the most advanced laboratory analysis and diagnostic genomics centre of the Mediterranean region.
The Architectural aspect is being taken care of by a leading local architectural firm. The building is being designed with a holistic approach, not only having its own architectural external identity, but also seeking to create a personal and welcoming environment that departs form the clinical coldness that is usually associated with hospitals. The structure will look like a modern, high-level hotel with 200 rooms, 50 of which would be suites. All rooms will be equipped with the latest comforts that seek to mimic a five-star superior hotel.
Energy efficiency and sustainability are important aspects being taken into consideration. The identification of alternative energy sources is also being sought through site-specific studies.
The management of the hospital will be through a specialised software. Talks are currently underway for a possible partnership with one of the most influential multinational software companies in the medical field, in order to develop an innovative management software programme that caters for a holistic system which encompasses both clinical and administrative aspects.
Training of local and international professional staff, including nurses and physiotherapists, is a vital aspect. The Company is open to collaborations with the University of Malta and other medical training institutions already existent in Malta.
The medical structure is open to the collaboration of the Maltese medical professionals.
The medical structure will set up both an Ethics Scientific Committee involving local medical expertise, and a foundation for social projects. Ties have already been established with the Dynamo Camp Association, a non-profit organisation specialising in recreation therapy programmes, to host children and teens (between 3 and 17) affected by chronic conditions (for instance, oncohematology, rare syndromes, spina bifida, diabetes etc.). The primary objective is to get Maltese children with such conditions, to participate and enjoy the Dynamo Camp Centre overseas free of charge. The foundation would bear all costs related to the same.
Although this medical centre is a private enterprise, the medical exigencies within the local context are still being taken into consideration. The Company confirms that it welcomes talks with the Government regarding current necessities within the local health sector. The projected timeline for the opening is mid-2017, and from these early stages The Company will engage in an information campaign locally and internationally, particularly in the Mediterranean basin, Northern Europe and the Middle East.
S. John Paul II
This name embodies an important persona which, beyond the religious aspect, is recognised as a strong symbol of humanity and selflessness. He is known as the man who brought world’s religions together, through a common identity, and who embodied the love and care towards all individuals and all nations.